Interview with En. Leonard Ariff Abd. Shatar, CEO, Chemical Company Malaysia…
Would you start off by giving our readers some of CCM’s background? CCM started in Malaysia as part of the ICI group of companies in 1930. In the 1960s ICI…
Address: 13th Floor, Menara PNB 201-A, Jalan Tun Razak 50400 Kuala Lumpur Malaysia
Tel: 603-2612 3888
Web: http://www.ccmberhad.com/
For over 70 years, CCM Chemicals has been a leading industrial and specialty chemicals company in Malaysia with full fledged offices across ASEAN. Chemical Company of Malaysia (CCM) has a significant corporate presence as a public listed company since 1966, initially as a subsidiary of ICI PLC of the United Kingdom and now as a Malaysian owned corporation. CCM Berhad has since progressed to become a ‘blue-chip’ company in the Main Board of Bursa Malaysia with good returns to shareholders.
CCM Group is one of the nation’s largest chemicals, fertilizers and healthcare companies, manufacturing a wide range of products to meet the growing needs of the domestic and overseas markets.
CCM is the largest local manufacturer of generic drugs with over 280 products including antihistamines, antibiotics and expectorants. They are also the leading over-the-counter (OTC) products manufacturer in the country with brands such as Champs, Proviton and Uphamol.
As an independent Malaysian company, CCM Group offers products and services to the chemicals, healthcare and agricultural industries.
Chemical products and applications
Fertilizers and technical advisory services
Pharmaceuticals and healthcare products and services
Our business operations are structured into four major subsidiaries: CCM Chemicals, CCM Fertilizers, CCM Pharmaceuticals and CCM Duopharma Biotech that are responsible for these activities.
Would you start off by giving our readers some of CCM’s background? CCM started in Malaysia as part of the ICI group of companies in 1930. In the 1960s ICI…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
Klinsel’s CEO discusses the company’s ambitions of growth in a very competitive CRO market and stresses that local experience is truly a distinguishing factor and this is why they are…
Novo Nordisk Malaysia’s general manager shares the ongoing fight to cure diabetes and talks about the necessity to raise awareness, with for instance their current MoU with the ministry of…
Malaysia Healthcare Travel Council’s CEO is proud of her country’s healthcare system and their efforts at attracting medical tourists from all over the world, with the support of the healthcare…
Mundipharma Malaysia’s country manager discusses his company’s aim to become a reference in Malaysia for pain management, on the back of the tremendous 48 percent growth of the business last year. …
Lundbeck’s country manager gives a thorough overview of CNS disorders in Malaysia and states: “It is important to remind everyone that mental health conditions or brain diseases are not to…
MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high quality doctors and strong government support. However,…
IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s general manager introduces this landmark and also…
Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing originators. Although Aspen is a renowned generic player, market dynamics…
MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time where most have decided to invest and base their…
See our Cookie Privacy Policy Here